Nucynta ER Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Nucynta ER
O
- Obenix (phentermine)
- Obephen (phentermine)
- Obezine (phendimetrazine)
- Obredon (guaifenesin / hydrocodone)
- Oby-Cap (phentermine)
- Oby-Trim (phentermine)
- Octocaine 100 (epinephrine / lidocaine)
- Ocu-Phrin (phenylephrine ophthalmic)
- Ocu-Zoline (naphazoline ophthalmic)
- OcuClear (oxymetazoline ophthalmic)
- Ocuhist (naphazoline / pheniramine ophthalmic)
- olanzapine
- olanzapine / samidorphan
- Oleptro (trazodone)
- oliceridine
- Olinvyk (oliceridine)
- olodaterol
- olodaterol / tiotropium
- olopatadine nasal
- Olumiant (baricitinib)
- Omidria (ketorolac / phenylephrine ophthalmic)
- Omnihist II LA (chlorpheniramine / methscopolamine / phenylephrine)
- Omnihist L.A. (chlorpheniramine / methscopolamine / phenylephrine)
- Omnipaque 12 (iohexol)
- Omnipaque 140 (iohexol)
- Omnipaque 180 (iohexol)
- Omnipaque 180 Redi-Unit (iohexol)
- Omnipaque 210 (iohexol)
- Omnipaque 240 (iohexol)
- Omnipaque 240 Redi-Unit (iohexol)
- Omnipaque 300 (iohexol)
- Omnipaque 350 (iohexol)
- Omnipaque 9 (iohexol)
- Omnipaque Flexipak (iohexol)
- OMS (morphine)
- ondansetron
- Onfi (clobazam)
- Ongentys (opicapone)
- Onset Forte (acetaminophen / chlorpheniramine / phenylephrine)
- Onsolis (fentanyl)
- Onyda XR (clonidine)
- Onzetra Xsail (sumatriptan)
- Opana (oxymorphone)
- Opana ER (oxymorphone)
- Opcon-A (naphazoline / pheniramine ophthalmic)
- opicapone
- opium
- Opium Deodorized (opium)
- Opium Tincture, Deodorized (opium)
- Opti-Clear (tetrahydrozoline ophthalmic)
- Optigene 3 (tetrahydrozoline ophthalmic)
- Optimine (azatadine)
- Or-Phen-Ade (chlorpheniramine / phenylpropanolamine)
- Orabloc (articaine / epinephrine)
- Oraltag (iohexol)
- Oramorph SR (morphine)
- Orap (pimozide)
- Oratuss (carbetapentane / guaifenesin)
- Oratuss 12 (carbetapentane / guaifenesin / phenylephrine)
- Orbivan (acetaminophen / butalbital / caffeine)
- Orbivan CF (acetaminophen / butalbital)
- Ordrine (chlorpheniramine / phenylpropanolamine)
- Ordrine AT (caramiphen / phenylpropanolamine)
- Orfro (orphenadrine)
- Orlaam (levomethadyl acetate)
- Orlenta (chlorpheniramine / pseudoephedrine)
- Ormazine (chlorpromazine)
- Ornade Spansules (chlorpheniramine / phenylpropanolamine)
- Ornex (acetaminophen / pseudoephedrine)
- Ornex Maximum Strength (acetaminophen / pseudoephedrine)
- orphenadrine
- Orphenate (orphenadrine)
- Orphengesic (aspirin / caffeine / orphenadrine)
- Orphengesic Forte (aspirin / caffeine / orphenadrine)
- Orvaten (midodrine)
- Oscimin (hyoscyamine)
- OsmoPrep (sodium biphosphate / sodium phosphate)
- Otrivin (xylometazoline nasal)
- Oxaydo (oxycodone)
- oxazepam
- oxcarbazepine
- Oxecta (oxycodone)
- Oxtellar XR (oxcarbazepine)
- oxybutynin
- Oxycet (acetaminophen / oxycodone)
- oxycodone
- OxyContin (oxycodone)
- Oxydose (oxycodone)
- Oxyfast (oxycodone)
- Oxyfrin (oxymetazoline nasal)
- OxyIR (oxycodone)
- Oxymeta-12 (oxymetazoline nasal)
- oxymetazoline nasal
- oxymetazoline ophthalmic
- oxymetazoline topical
- oxymorphone
- Oxytrol (oxybutynin)
- Oxytrol for Women (oxybutynin)
- ozanimod
- Ozobax (baclofen)
- Ozobax DS (baclofen)
More about Nucynta ER (tapentadol)
- Nucynta ER consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (81)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: Opioids (narcotic analgesics)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.